With public pressure to reduce drug spending, payers are increasingly using formulary tools to help manage market access. This article examines factors driving the success of market access strategies.
MARKET access strategy is complex, dynamic, and constantly evolving. Biopharma leaders can optimize market access across a portfolio of products by analyzing how therapeutic area (TA) dynamics, including the level of competition, could influence the use of payer tools to manage access. Over the last several years, payers have increasingly used formulary tiering as one tool to help control and manage market access. With intensifying public pressure to reduce drug spending, this trend is likely to continue. However, not all TAs are impacted equally. Our analysis of the degree to which competition drives formulary positioning across eight TAs reveals insights on what additional dynamics could be driving formulary positioning, a proxy for the success of market access strategies. ... |